The company in my opinion is on the right track.
It has become quite lean in the past financial year due to cuts of ~35% to operating expenses. They have restructured their offering from a lot of products to two. Simple is better as it reduces the complexity of understanding what LVT does. They are focusing on what has worked - Reach (licences grew 1200% last year). This is their ticket to growing the ARR.
They are coming off a tough COVID year and with vaccines allow countries to open up, it will allow more opportunities to sell to large enterprises. I think the worst is behind us and the facts seem to indicate that as well.
- Forums
- ASX - By Stock
- LVT
- Who is buying/selling and why?
Who is buying/selling and why?, page-79
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
Add LVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.474M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LVT (ASX) Chart |
Day chart unavailable